RNA interference in animals involves small double-stranded RNA molecules called siRNA. These molecules are valuable tools for studying single gene function in both in vivo and in vitro settings and are also considered a promising class of therapeutics. SiRNA delivery systems fall into two categories: viral and non-viral, including peptides, polymers, and lipids. Studies using synthetic or plasmid-encoded siRNA show its antiviral effects against various viruses, including SARS-CoV. Learn more about siRNA for Treatment of SARS-CoV-2: https://sars-cov-2.creative-biolabs.com/sirna-for-the-treatment-of-sars-cov2.htm

BioNTech, which co-developed a revolutionary mRNA covid-19 vaccine in partnership with Pfizer, hopes to revolutionise another area of pharmaceuticals: vaccine manufacturing. It is developing vaccine factories to sit inside a series of standard metal shipping containers, which it plans to send to parts of the world that lack their own vaccine-manufacturing capabilities-notably Africa. Each facility, BioNTech says, will be able to produce up to 60m doses of covid vaccines and other vaccines each year, and will cost "significantly less" than conventional factories. If so, this could be the future of drugmaking. https://www.economist.com/science-and-technology/biontech-plans-to-make-vaccines-in-shipping-containers/

The 2022 LinkedIn Jobs on the Rise list reveals the 15 fastest-growing job titles over the past five years and the trends defining